24 REAL-WORLD COMPARISON OF TOFACITINIB VERSUS USTEKINUMAB AMONG ULCERATIVE COLITIS PATIENTS WITH PRIOR ANTI-TUMOR NECROSIS FACTOR ALPHA AND ANTI-INTEGRIN TREATMENT FAILURE: A PROPENSITY SCORE-ADJUSTED ANALYSIS

2021 ◽  
Vol 160 (6) ◽  
pp. S-5
Author(s):  
Rahul S. Dalal ◽  
Jennifer Mitri ◽  
Hannah Goodrick ◽  
Jessica R. Allegretti
2008 ◽  
Vol 103 (2) ◽  
pp. 407-415 ◽  
Author(s):  
Megan M. Garrity-Park ◽  
Edward V. Loftus ◽  
Sandra C. Bryant ◽  
William J. Sandborn ◽  
Thomas C. Smyrk

Sign in / Sign up

Export Citation Format

Share Document